PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide

NCT00744224 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Glucocorticoid-induced Glucometabolic Abnormalities
Glucocorticoid-induced Beta-cell Dysfunction

Interventions

DRUG: Placebo
DRUG: Prednisolone
DRUG: Prednisolone and Exenatide

Sponsor

Amsterdam UMC, location VUmc

Collaborators

[object Object]